Navigation Links
Endo Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:4/29/2009

ura in adults; OPANA(R) tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; OPANA(R) ER tablets for the relief of moderate-to-severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time; and Voltaren(R)Gel, a nonsteroidal anti-inflammatory drug indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as those of the hands and the knees. Voltaren(R)Gel is owned and licensed by Novartis AG; SANCTURA(R) and its XR version for treatment of overactive bladder, VANTAS(R) for the palliative treatment of advanced prostate cancer, and SUPPRELIN(R) LA for the treatment of early onset puberty in children. The company markets its branded pharmaceutical products to physicians in pain management, neurology, surgery, oncology, and primary care. More information, including this and past press releases of Endo Pharmaceuticals, is available at www.endo.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the acquisition of Indevus, the company's financial position, results of operations, market position, product development and business strategy, as well as estimates of future net sales, future expenses, future net income and future earnings per share. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "intend," "guidance" or similar expressions are forward-looking statements. Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors could affect our future financial results a
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Liver is the largest organ inside the ... the body in barring itself from poisons, helps in digestion ... also plays many important functions such as protein production, blood ... Many illnesses can affect the liver, an organ the size ... the right side of the abdomen, reducing its capabilities to ...
(Date:9/1/2014)... "Women struggle with weight gain typically associated ... as early as 15, if not earlier. Women ... and downs of hormone related weight gain. The ... seems to rage against the hidden and ever-present hormones ... 40's begin to face menopause and related changes, these ...
(Date:9/1/2014)... Spain Monday 1 September 2014: Permanent atrial fibrillation ... AF, according to research in more than 6 000 ... Vanassche from Belgium. The findings suggest that a simple ... doctors to better estimate stroke risk. , Ischaemic stroke ... accounting for over a million deaths and many more ...
(Date:9/1/2014)... York (PRWEB) September 01, 2014 ... retrieve, organize and analyze biological and genetic data. ... the activity of developing software tools to generate ... to be confused with biological computation. While bioinformatics ... understanding of biology can its related concepts, biological ...
(Date:9/1/2014)... September 01, 2014 Top10BestSEOHosting.com has ... many web host suppliers carefully, Top10BestSEOHosting.com is here ... the best web hosting suppliers in 2014. , ... clients with a top-of-the-line shared hosting plan. The ... easy-to-use platform that is affordable, accessible and powerful ...
Breaking Medicine News(10 mins):Health News:Global Liver Diseases and Therapies Market- The Key Basics by Transparency Market Research 2Health News:Global Liver Diseases and Therapies Market- The Key Basics by Transparency Market Research 3Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3Health News:Permanent AF doubles risk of stroke compared to paroxysmal AF 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2
... , MONDAY, Oct. 3 (HealthDay News) -- Even ... as depression, vision problems and difficulty thinking, according to a ... Canadian Stroke Congress in Ottawa, suggest new guidelines are needed ... said. "There is no such thing as a mild ...
... MDA recent study accepted for publication in Molecular Endocrinology, ... exposure to environmentally relevant doses of bisphenol A (BPA) ... that may increase the propensity to develop cancer. ... specific industrial purposes, is detected in body fluids of ...
... Not only are smokers twice as likely to have strokes, ... have them, according to a study presented today at the ... researchers studied 982 stroke patients (264 smokers and 718 non-smokers) ... of stroke patients who smoked was 58, compared to age ...
... is common among patients with gout. According to the ... peer-reviewed journal of the American College of Rheumatology (ACR), ... foot-related pain, impairment and disability. Gout patients also reported ... important factors for selecting footwear. Gout is a ...
... South Africa and Brazil become happier as they age. New ... developing country can significantly improve the wellbeing of its older ... people in South Africa and Brazil improved between 2002 and ... social policies, according to a study from the New Dynamics ...
... Oct. 2 (HealthDay News) --,Children can enjoy some Halloween candy ... Mitchell, a Chicago dentist. Mitchell said the key to ... of candy children eat, but also how long the sugar ... possible after eating candy may keep harmful bacteria from developing, ...
Cached Medicine News:Health News:Mild Strokes May Have Hidden Effects 2Health News:BPA exposure in utero may increase predisposition to breast cancer 2Health News:Smoking causes stroke to occur 2Health News:Poor footwear linked to foot impairment and disability in gout patients 2Health News:Older people are happier in Brazil and South Africa 2
(Date:8/29/2014)... , Aug. 29, 2014 Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... in the 2014 Morgan Stanley Global Healthcare Conference on ... , President and Chief Executive Officer, will provide an ... Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
(Date:8/29/2014)... 29, 2014 Research and Markets  has announced ... Insight 2014" report to their offering. ... one of the largest segments of pharmaceuticals industry. The numbers ... the available therapies were unable to meet the market requirements. ... for CNS disorder, especially over the past two decades. The ...
(Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2
... Oswego, Oregon based ThermoGear, Inc., partnered with DVM Solutions, ... new high technology veterinary surgical system that took place ... Florida.  The Chillbuster®VET Surgical Blanket and Cage Mat are ... Veterinarians who have been testing the system. ...
... Corporation (NYSE: BSX ) today announced the ... which is designed to assess the safety and performance ... single-blind, non-inferiority trial will compare the SYNERGY Stent to ... a single de novo native coronary artery ...
Cached Medicine Technology:High Tech Vet Medical Warming System Introduced at Orlando 2High Tech Vet Medical Warming System Introduced at Orlando 3Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent 2Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent 3Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent 4
Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option....
System, English (Continental cord), 230 VAC....
300XL System, English (U.K. cord), 100-240 VAC....
Micro-mini fiber optic light....
Medicine Products: